A new patient support programme designed for those living with relapsing forms of multiple sclerosis (MS) has been developed by Teva Pharmaceuticals.
The MS Care programme delivers personalised and flexible digital support to complement care from healthcare professionals, in order to improve patients’ overall quality of life and help them to understand how best to manage life with MS.
MS Care involves completion of a questionnaire, which then provides a bespoke programme created to meet their individual needs, beliefs and attitudes that will help them gain the most from their treatment, increase their confidence, and feel more equipped to manage their condition.
“Knowing that each reaction to a diagnosis of MS is unique, we took particular care to build a support programme that meets the diverse needs of all patients,” said Marc van Kempen, VP global development, patient solutions at Teva. “We are excited about the launch of our advanced MS Care Programme and look forward to making it available in individual markets in the coming months.”